EMTRIVA

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Spain, UK.

Active ingredients

The drug EMTRIVA contains one active pharmaceutical ingredient (API):

1	Emtricitabine UNII G70B4ETF4S - EMTRICITABINE
	Emtricitabine is a synthetic nucleoside analogue of cytidine with activity that is specific to HIV-1, HIV-2 and HBV. Emtricitabine is phosphorylated by cellular enzymes to form emtricitabine 5'-triphosphate, which competitively inhibits HIV-1 reverse transcriptase, resulting in DNA chain termination. Emtricitabine is a weak inhibitor of mammalian DNA polymerase α, β and ε and mitochondrial DNA polymerase γ.
	Read more about Emtricitabine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EMTRIVA Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)
EMTRIVA Oral solution	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AF09	Emtricitabine	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1199976, 1199987
ES	Centro de información online de medicamentos de la AEMPS	03261001, 03261003
FI	Lääkealan turvallisuus- ja kehittämiskeskus	016973
FR	Base de données publique des médicaments	61294762, 66717579
GB	Medicines & Healthcare Products Regulatory Agency	53797, 91819
JP	医薬品医療機器総合機構	6250028M1029
LT	Valstybinė vaistų kontrolės tarnyba	1027987, 1027988, 1027989
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	494M2004
NL	Z-Index G-Standaard, PRK	74292
NZ	Medicines and Medical Devices Safety Authority	11353
PL	Rejestru Produktów Leczniczych	100127619, 100127625
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W51483001, W64753001, W64753002
US	FDA, National Drug Code	61958-0601, 61958-0602, 70518-1847